SCHEMBL9900358

SCHEMBL9900358

CC/C(CC(=O)c1ccccc1)=N\OS(=O)(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ HPGD P15428 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ CES1 P23141 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ HSD11B1 P28845 6/20 0.42
▸ NPC1 O15118 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.40
▸ PTPN1 P18031 1/20 0.39
▸ ERCC5 P28715 1/20 0.39
▸ FEN1 P39748 1/20 0.39
▸ RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9900361 1.00 KDM4E (0.44) KDM4EMAPTKMT2ASMN1; SMN2HPGD
SCHEMBL2044767 0.86 KDM4E (0.44) KDM4EMAPTKMT2ASMN1; SMN2HPGD
SCHEMBL2044763 0.86 KDM4E (0.44) KDM4EMAPTKMT2ASMN1; SMN2HPGD
SCHEMBL214492 0.85 MAPT (0.49) KDM4EMAPTKMT2ASMN1; SMN2MAPK1
SCHEMBL9898198 0.85 KDM4E (0.43) KDM4EMAPTKMT2ASMN1; SMN2HPGD
SCHEMBL9898197 0.85 KDM4E (0.43) KDM4EMAPTKMT2ASMN1; SMN2HPGD
SCHEMBL2049582 0.83 MAPT (0.43) KDM4EMAPTKMT2ASMN1; SMN2MAPK1
SCHEMBL9898870 0.83 KDM4E (0.46) KDM4EMAPTKMT2ASMN1; SMN2HPGD
SCHEMBL9898869 0.83 KDM4E (0.46) KDM4EMAPTKMT2ASMN1; SMN2HPGD
SCHEMBL2049584 0.83 MAPT (0.43) KDM4EMAPTKMT2ASMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025024507-A1 MELANOGENESIS INHIBITION COMPOSITIONS AND METHODS OF USE THEREOF MDI BIOLOGICAL LABORATORY (US) 2025-01-30 — — WO claimed
US-8748531-B2 Polymers functionalized with oxime compounds containing an acyl group BRIDGESTONE CORPORATION (JP) 2014-06-10 — — US claimed
US-20120149833-A1 POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP BRIDGESTONE CORPORATION (JP) 2012-06-14 — — US claimed
WO-2025024507-A1 MELANOGENESIS INHIBITION COMPOSITIONS AND METHODS OF USE THEREOF MDI BIOLOGICAL LABORATORY (US) 2025-01-30 — — WO disclosed
EP-2649102-B1 POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP BRIDGESTONE CORP (JP) 2014-11-26 — — EP disclosed
US-8748531-B2 Polymers functionalized with oxime compounds containing an acyl group BRIDGESTONE CORPORATION (JP) 2014-06-10 — — US disclosed
US-20120149833-A1 POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP BRIDGESTONE CORPORATION (JP) 2012-06-14 — — US disclosed
Send feedback